Is anyone on this trial?
https://clinicaltrials.gov/ct2/show/NCT02143401
The phase 2 study of Sorafenib alone was rather disappointing for synovial sarcoma:
http://jco.ascopubs.org/content/27/19/3133.long
While an early study suggested it may help:
http://www.ncbi.nlm.nih.gov/pubmed/19633425
Could adding Navitoclax, a bcl-2 inhibitor improve the results?